Reliance Life Sciences is developing
a wide range of novel research-led, cell-based
therapies with the objective of bringing
about an era of regenerative medicine.
Several groups work in the areas of:
- Embryonic Stem Cells
- Ocular Stem Cells
- Haematopoietic Stem Cells
- Skin and tissue engineering
- Stem Cell Enriched Cord Blood Repository
- Assisted Reproduction
- Cell-based vaccines and immunotherapy
Cell-based therapies from Reliance Life
Sciences aim to meet unmet patient needs
in the areas of:
- Cardiac disorders
- Neural degeneration
- Spinal injury
- Metabolic disorders
- Ophthalmic diseases
- Hematological diseases
- Oncological diseases
- Burns and wound management
- Diabetic and Venous ulcers
- Skin pigmentation disorders
- Orthopaedic and cartilage disorders
- Infertility disorders
The Cell Biology initiative of Reliance
Life Sciences is uniquely integrated,
horizontally across several cell biology
disciplines, and vertically, from repository
infrastructure through basic and applied
research to clinical research and cell
processing cGMP suites.
